EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Latest
Pharmacy coalition to congressional leaders: Enact PBM reform now to protect patient access and reduce Americans' drug costs
National pharmacy organizations warn Congress that failure to curb abusive PBM practices has escalated from an emerging threat to an unaddressed crisis for patients and pharmacies.
RxConnexion announces launch of RxConnexionTV
Officially launching on January 1, 2026, RxConnexionTV marks a historic milestone for the profession by creating a centralized media platform built by pharmacy, for pharmacy.
How Americans are really losing weight
From intermittent fasting to GLP-1s, Americans are rethinking how they lose weight—and what "healthy" really looks like.
Neutrogena rolls out two new prestige inspired Ultra Sheer sunscreens
New additions continue to raise the bar for high-performance daily SPF.